152 related articles for article (PubMed ID: 7194054)
1. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
Ginocchio AV; Metz G
Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Davies JE; Kellett DN
Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
[TBL] [Abstract][Full Text] [Related]
3. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
5. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
7. [Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
Lücker PW; Wetzelsberger K; Erking W; Donike M
Arzneimittelforschung; 1980; 30(11b):2045-53. PubMed ID: 7194058
[TBL] [Abstract][Full Text] [Related]
8. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
Sim AK; Davies ME; McCraw AP; Metz G
Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
[TBL] [Abstract][Full Text] [Related]
9. [On the uricosuric activity of etofylline clofibrate (author's transl)].
Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2073-4. PubMed ID: 7194063
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effects and tolerance of etofylline clofibrate].
Ziegler WJ; Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacology and toxicology of etofylline clofibrate].
Sterner W; Korn WD
Arzneimittelforschung; 1980; 30(11b):2023-31. PubMed ID: 7194053
[TBL] [Abstract][Full Text] [Related]
12. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
13. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2014-9. PubMed ID: 7194051
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
Ritschel WA; Thompson GA; Lücker PW; Wetzelsberger K
Arzneimittelforschung; 1980; 30(11b):2020-3. PubMed ID: 7194052
[TBL] [Abstract][Full Text] [Related]
15. Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
Metz G; Sim AK; McCraw AP; Cleland ME
Arzneimittelforschung; 1986 Sep; 36(9):1363-5. PubMed ID: 3539125
[TBL] [Abstract][Full Text] [Related]
16. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
17. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
18. Xanthone analogues of clofibrate / Synthesis and biological evaluation as antagonists of lipolysis in vitro.
Gaion RM; Valenti P; Montanari P; Da Re P
Arzneimittelforschung; 1982; 32(5):499-502. PubMed ID: 7201826
[TBL] [Abstract][Full Text] [Related]
19. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
Metz G; Specker M
Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
Stevens TJ; Stafford WW; Day CE; Block EM
Artery; 1983; 12(2):81-94. PubMed ID: 6678582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
